Measurement of a Systolic Pressure Index at the Toe After a Walking Test

NCT ID: NCT01750944

Last Updated: 2015-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to evaluate the concordance of the variation in systolic pressure indices measured at the toe and ankle after a walking test in healthy volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our secondary objectives are:

* to evaluate the concordance between left- and right-side measures: systolic pressure indices measured at the toe after a walking test (healthy volunteers)
* to evaluate the concordance between left- and right-side measures: systolic pressure indices measured at the ankle after a walking test (healthy volunteers)
* to evaluate the concordance of the variation in systolic pressure indices measured at the toe and ankle during the recuperation phase after a walking test (5 and 10 minutes after end of walking test) in healthy volunteers

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Good Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Volunteers 1

The study population consists of adult, healthy volunteers randomized into two identical groups.

Intervention: ankle first

Group Type EXPERIMENTAL

Ankle first

Intervention Type PROCEDURE

1. Brachial blood pressure on both the left and right (BBP-LR) sides is measured, as well as at the left and right ankles (BPA-LR).
2. A 15 minute walking test (WT) is performed.
3. BBP-LR and BPA-LR are re-measured.
4. 2 hours of rest.
5. BBP-LR and the blood pressure at the left and right big toes (BPT-LR) are measured.
6. WT is reperformed.
7. BBP-LR and BPT-LR are re-measured.

Healthy Volunteers 2

The study population consists of adult, healthy volunteers randomized into two identical groups.

Intervention: toe first

Group Type EXPERIMENTAL

Toe first

Intervention Type PROCEDURE

1. Brachial blood pressure on both the left and right (BBP-LR) sides is measured, as well as at the left and right big toes (BPT-LR).
2. A 15 minute walking test (WT) is performed.
3. BBP-LR and BPT-LR are re-measured.
4. 2 hours of rest.
5. BBP-LR and the blood pressure at the left and right ankles (BPA-LR) are measured.
6. WT is reperformed.
7. BBP-LR and BPA-LR are re-measured.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ankle first

1. Brachial blood pressure on both the left and right (BBP-LR) sides is measured, as well as at the left and right ankles (BPA-LR).
2. A 15 minute walking test (WT) is performed.
3. BBP-LR and BPA-LR are re-measured.
4. 2 hours of rest.
5. BBP-LR and the blood pressure at the left and right big toes (BPT-LR) are measured.
6. WT is reperformed.
7. BBP-LR and BPT-LR are re-measured.

Intervention Type PROCEDURE

Toe first

1. Brachial blood pressure on both the left and right (BBP-LR) sides is measured, as well as at the left and right big toes (BPT-LR).
2. A 15 minute walking test (WT) is performed.
3. BBP-LR and BPT-LR are re-measured.
4. 2 hours of rest.
5. BBP-LR and the blood pressure at the left and right ankles (BPA-LR) are measured.
6. WT is reperformed.
7. BBP-LR and BPA-LR are re-measured.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject must have given his/her informed and signed consent
* The subject must be insured or beneficiary of a health insurance plan

Exclusion Criteria

* The subject is in an exclusion period determined by a previous study
* The subject is under judicial protection, under tutorship or curatorship
* The subject refuses to sign the consent
* It is impossible to correctly inform the subject
* The subject is pregnant, parturient, or breastfeeding
* The subject has a contraindication for a walking test
* Presence of mediacalcose objectified by a Doppler examination of the anterior and posterior tibial arteries, performed on the test day
* Known history of cardiovascular disease
* Poorly controlled diabetes or hypertension
* Neurological, muscular or rheumatic pathology contra-indicating a walking test
* Acute transient infection (cold-rhinitis, flu, etc.)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antonia Perez Martin, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Universitaire de Nîmes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012-A01432-41

Identifier Type: OTHER

Identifier Source: secondary_id

LOCAL/2012/APM-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.